It is a healthcare private limited company based in Hubballi, Karnataka, India, established in 2018.
2018 | Hubballi, Karnataka, India | ActiveKarunadu Oncology Haematology Associates Private Limited, a active private limited company, was established on 18 December 2018 in Hubballi, Karnataka, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85320KA2018PTC119596. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.30 Cr.
Its leadership includes Jagadish Tubachi Basavaraj (Director), Pran Prasa Nna Hanumanthu (Director), Lakshmi (Director). Past directors included Pran Prasa Nna Hanumanthu. It holds ₹10.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Madura Chetana Colony 123 Keshwapur, Hubballi, Karnataka, 580023.
U85320KA2018PTC119596
119596
18 December 2018
₹5.00 Cr
₹4.30 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Karunadu Oncology Haematology Associates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagadish Tubachi Basavaraj | Director | 18 Dec 2018 | Current |
| Pran Prasa Nna Hanumanthu | Director | 01 Aug 2022 | Current |
| Lakshmi | Director | 26 Jun 2021 | Current |
| Rajeev | Director | 26 Jun 2021 | Current |
| Snehalreddy | Director | 18 Dec 2018 | Current |
| Santosh Chandru Kulgod | Director | 20 Jun 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Karunadu Oncology Haematology Associates Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Karunadu Oncology Haematology Associates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹100,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2021 | State Bank Of India | ₹10.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Karunadu Oncology Haematology Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Karunadu Oncology Haematology Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karunadu Oncology Haematology Associates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gajula Mehar Kumar was appointed as a Director was appointed as a Director on 24 Nov 2025 & has been associated with this company since 1 month 16 days . was documented.
Progress on Karunadu Oncology Haematology Associates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Karunadu Oncology Haematology Associates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Pran Prasa Nna Hanumanthu was appointed as a Director was appointed as a Director on 01 Aug 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.
A charge with State Bank Of India amounted to Rs. 10.00 Cr with Charge ID 100482240 was registered on 27 Sep 2021. was recorded as a recent event.
Lakshmi was appointed as a Director was appointed as a Director on 26 Jun 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.
The CIN of Karunadu Oncology Haematology Associates Private Limited is U85320KA2018PTC119596.
Karunadu Oncology Haematology Associates Private Limited is headquartered at Madura Chetana Colony 123 Keshwapur, Hubballi, Karnataka, 580023.
Karunadu Oncology Haematology Associates Private Limited was incorporated on 18 December 2018.
The current directors of Karunadu Oncology Haematology Associates Private Limited are
The primary industry of Karunadu Oncology Haematology Associates Private Limited is Hospital And Medical Care.
Karunadu Oncology Haematology Associates Private Limited is unlisted.
The authorized capital of Karunadu Oncology Haematology Associates Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.30 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX